AZD-4017

DB14875InvestigationalSmall molecule

AZD-4017 is under investigation in clinical trial NCT01173471 (A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure).

Mechanism: Pharmacologically active on 11-beta-hydroxysteroid dehydrogenase 1
Curator reviewed
Formula / weight: C₂₂H₃₃N₃O₃S · 419.581 g/mol (avg)
Code names: AZD-4017

Resolves to

Compound

UNII3JL137394YCAS1024033-43-9ChEMBLCHEMBL2153191

Structure

InChIKeyNCDZABJPWMBMIQ-INIZCTEOSA-NSMILESCCCSC1=C(C=CC(=N1)N1CCC[C@@H](CC(O)=O)C1)C(=O)NC1CCCCC1

Targets

P28845HSD11B1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with AZD-4017, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account